Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8 | -16,352 | -10,759 | -634 | -20,965 |
| Depreciation Amortization | -657 | -924 | -113 | 516 | 1 |
| Accounts payable and accrued liabilities | -1,124 | 796 | -689 | -308 | 415 |
| Other Working Capital | -964 | 2,008 | -924 | -4,595 | 1,521 |
| Other Operating Activity | 1,516 | 2,607 | 515 | 610 | 3,725 |
| Operating Cash Flow | $-1,221 | $-11,866 | $-11,969 | $-4,411 | $-15,303 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -90 | -13 | -134 | -8 | N/A |
| Purchase Of Investment | -32,864 | -22,902 | -45,075 | -48,423 | -6,315 |
| Sale Of Investment | 35,400 | 36,000 | 59,502 | 4,650 | 10,208 |
| Investing Cash Flow | $2,446 | $13,085 | $14,294 | $-43,780 | $3,893 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 234 |
| Debt Repayment | N/A | N/A | -1,667 | -3,333 | -1,667 |
| Common Stock Issued | 209 | 405 | 190 | 26,852 | 22,332 |
| Other Financing Activity | 0 | 0 | -650 | 3,406 | 0 |
| Financing Cash Flow | $209 | $405 | $-2,127 | $26,925 | $20,899 |
| Beginning Cash Position | 4,772 | 3,149 | 2,951 | 24,217 | 14,729 |
| End Cash Position | 6,206 | 4,772 | 3,149 | 2,951 | 24,217 |
| Net Cash Flow | $1,434 | $1,623 | $198 | $-21,267 | $9,489 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,221 | -11,866 | -11,969 | -4,411 | -15,303 |
| Capital Expenditure | -90 | -13 | -134 | -8 | N/A |
| Free Cash Flow | -1,311 | -11,879 | -12,103 | -4,419 | -15,303 |